epocrates logo
epocrates logo
epocrates logo
  • 0

Diseases

Evaluation of acute motor deficit

OVERVIEW

  • Summary
  • Urgent Considerations
  • Etiology

DIAGNOSIS

  • Differential Diagnosis
  • Diagnostic Approach

IMAGES

  • Library

REFERENCES

  • Citations
  • Credits

Summary

AAFont SizeShareMore Information
Acute motor deficits occur when there is either a sudden loss of connectivity between the central nervous system (CNS) and the muscles or there is dysfunction of the muscles themselves.
Loss of connection can occur anywhere from the CNS to the motor-end plate.
Careful questioning of people who report sudden motor loss can help determine the exact anatomy of the motor deficit, any accompanying features, and the likely pathophysiology. The anatomic description of the deficit helps localize the site of dysfunction. This may include the brain, spinal cord, peripheral nerves, and muscles.
Acute motor deficits occur in a wide range of disease states. Once the probable site of dysfunction has been identified, consideration can be given to the likely type of process involved: vascular, trauma, infection, autoimmune/inflammatory, metabolic, compression, or other.
There can be considerable overlap in presentations. For example, a sudden loss of motor function might often have a vascular cause, but other conditions such as edema related to a tumor in the white matter, or chronic subdural hematoma can present with a similar history, albeit less frequently.
Motor deficits can be intermittent, relapsing, or acute and catastrophic, although these features do not always help define the pathophysiology.
content by BMJ Group
Last updated

Citations

    Key Articles

    • Powers WJ, Rabinstein AA, Ackerson T, et al. Guidelines for the early management of patients with acute ischemic stroke: 2019 update to the 2018 guidelines for the early management of acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2019 Dec;50(12):e344-418.[Abstract][Full Text]

    • Scottish Intercollegiate Guidelines Network, Royal College of Physicians. National clinical guideline for stroke for the United Kingdom and Ireland. Apr 2023 [internet publication].[Full Text]

    • ​American College of Radiology​. ACR appropriateness criteria: cerebrovascular disease. 2016 [internet publication].[Full Text]

    • Greenberg SM, Ziai WC, Cordonnier C, et al. 2022 Guideline for the management of patients with spontaneous intracerebral hemorrhage: a guideline from the American Heart Association/American Stroke Association. Stroke. 2022 Jul;53(7):e282-361.[Abstract][Full Text]

    Referenced Articles

    • 1. Förster A, Griebe M, Wolf ME, et al. How to identify stroke mimics in patients eligible for intravenous thrombolysis? J Neurol. 2012 Jul;259(7):1347-53.[Abstract]

    • 2. Asan Z. Spinal concussion in adults: transient neuropraxia of spinal cord exposed to vertical forces. World Neurosurg. 2018 Jun;114:e1284-9.[Abstract][Full Text]

    • 3. Fagre AC, Lyons S, Staples JE, et al. West nile virus and other nationally notifiable arboviral diseases - United States, 2021. MMWR Morb Mortal Wkly Rep. 2023 Aug 25;72(34):901-6.[Abstract][Full Text]

    • 4. Dimachkie MM, Barohn RJ. Guillain-Barré syndrome and variants. Neurol Clin. 2013 May;31(2):491-510.[Abstract][Full Text]

    • 5. Nayak L, Lee EQ, Wen PY. Epidemiology of brain metastases. Curr Oncol Rep. 2012 Feb;14(1):48-54.[Abstract][Full Text]

    • 6. Powers WJ, Rabinstein AA, Ackerson T, et al. Guidelines for the early management of patients with acute ischemic stroke: 2019 update to the 2018 guidelines for the early management of acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2019 Dec;50(12):e344-418.[Abstract][Full Text]

    • 7. Scottish Intercollegiate Guidelines Network, Royal College of Physicians. National clinical guideline for stroke for the United Kingdom and Ireland. Apr 2023 [internet publication].[Full Text]

    • 8. ​American College of Radiology​. ACR appropriateness criteria: cerebrovascular disease. 2016 [internet publication].[Full Text]

    • 9. Hacke W, Kaste M, Bluhmki E, et al. ECASS Investigators. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med. 2008 Sep 25;359(13):1317-29.[Abstract][Full Text]

    • 10. National Institute for Health and Care Excellence. Stroke and transient ischaemic attack in over 16s: diagnosis and initial management. April 2022 [internet publication].[Full Text]

    • 11. Rodrigues FB, Neves JB, Caldeira D, at al. Endovascular treatment versus medical care alone for ischaemic stroke: systematic review and meta-analysis. BMJ. 2016 Apr 18;353:i1754.[Abstract][Full Text]

    • 12. Alamowitch S, Turc G, Palaiodimou L, et al. European Stroke Organisation (ESO) expedited recommendation on tenecteplase for acute ischaemic stroke. 2023 Feb;8(1):8-54.​[Full Text]

    • 13. Alamowitch S, Turc G, Palaiodimou L, et al. European Stroke Organisation (ESO) expedited recommendation on tenecteplase for acute ischaemic stroke. Eur Stroke J. 2023 Mar;8(1):8-54.[Abstract][Full Text]

    • 14. Sames TA, Storrow AB, Finkelstein JA, et al. Sensitivity of new-generation computed tomography in subarachnoid hemorrhage. Acad Emerg Med. 1996 Jan;3(1):16-20.[Abstract][Full Text]

    • 15. Perry JJ, Stiell IG, Sivilotti ML, et al. Sensitivity of computed tomography performed within six hours of onset of headache for diagnosis of subarachnoid haemorrhage: prospective cohort study. BMJ. 2011 Jul 18;343:d4277.[Abstract][Full Text]

    • 16. Backes D, Rinkel GJ, Kemperman H, et al. Time-dependent test characteristics of head computed tomography in patients suspected of nontraumatic subarachnoid hemorrhage. Stroke. 2012 Aug;43(8):2115-9.[Abstract][Full Text]

    • 17. Dubosh NM, Bellolio MF, Rabinstein AA, et al. Sensitivity of Early Brain Computed Tomography to Exclude Aneurysmal Subarachnoid Hemorrhage: A Systematic Review and Meta-Analysis. Stroke. 2016 Mar;47(3):750-5.[Abstract][Full Text]

    • 18. Gajdos P, Chevret S, Toyka KV. Intravenous immunoglobulin for myasthenia gravis. Cochrane Database Syst Rev. 2012 Dec 12;12(12):CD002277.[Abstract][Full Text]

    • 19. Makarious D, Horwood K, Coward JIG. Myasthenia gravis: An emerging toxicity of immune checkpoint inhibitors. Eur J Cancer. 2017 Sep;82:128-36.[Abstract][Full Text]

    • 20. Le Quintrec JS, Le Quintrec JL. Drug-induced myopathies. Baillieres Clin Rheumatol. 1991 Apr;5(1):21-38.[Abstract]

    • 21. Dalakas MC. Toxic and drug-induced myopathies. J Neurol Neurosurg Psychiatry. 2009 Aug;80(8):832-8.[Abstract][Full Text]

    • 22. Amin HP, Madsen TE, Bravata DM, et al. Diagnosis, workup, risk reduction of transient ischemic attack in the emergency department setting: a scientific statement from the American Heart Association. Stroke. 2023 Mar;54(3):e109-21.[Abstract][Full Text]

    • 23. Perez DL, Aybek S, Popkirov S, et al. A review and expert opinion on the neuropsychiatric assessment of motor functional neurological disorders. J Neuropsychiatry Clin Neurosci. 2021 Winter;33(1):14-26.[Abstract][Full Text]

    • 24. ​Beca J, Sidebotham D. Chapter 37 - neurologic dysfunction. In: Andrew M, Michael G, Jerrold HL, ed(s). Cardiothoracic critical care. Philadelphia, PA: Butterworth-Heinemann;2009: 548-62.

    • 25. Thomas KE, Hasbun R, Jekel J, et al. The diagnostic accuracy of Kernig's sign, Brudzinski's sign, and nuchal rigidity in adults with suspected meningitis. Clin Infect Dis. 2002 Jul 1;35(1):46-52.[Abstract][Full Text]

    • 26. Kishnani PS, Austin SL, Abdenur JE, et al. Diagnosis and management of glycogen storage disease type I: a practice guideline of the American College of Medical Genetics and Genomics. Genet Med. 2014 Nov;16(11):e1.[Abstract][Full Text]

    • 27. Mirzayan MJ, Gharabaghi A, Samii M, et al. The diagnostic value of erythrocyte sedimentation rate in management of brain tumors. Neurol Res. 2009 Jun;31(5):514-7.[Abstract]

    • 28. Luzzani A, Polati E, Dorizzi R, et al. Comparison of procalcitonin and C-reactive protein as markers of sepsis. Crit Care Med. 2003 Jun;31(6):1737-41.[Abstract]

    • 29. Schuetz P, Christ-Crain M, Müller B. Procalcitonin and other biomarkers for the assessment of disease severity and guidance of treatment in bacterial infections. Jan 2008 [internet publication].[Full Text]

    • 30. Yealy DM, Fine MJ. Measurement of serum procalcitonin: a step closer to tailored care for respiratory infections? JAMA. 2009 Sep 9;302(10):1115-6.[Abstract]

    • 31. Meisner M, Tschaikowsky K, Palmaers T, et al. Comparison of procalcitonin (PCT) and C-reactive protein (CRP) plasma concentrations at different SOFA scores during the course of sepsis and MODS. Crit Care. 1999;3(1):45-50.[Abstract][Full Text]

    • 32. Oomes PG, van der Meché FG, Kleyweg RP. Liver function disturbances in Guillain-Barré syndrome: a prospective longitudinal study in 100 patients. Dutch Guillain-Barré study group. Neurology. 1996 Jan;46(1):96-100.[Abstract]

    • 33. Durand MC, Porcher R, Orlikowski D, et al. Clinical and electrophysiological predictors of respiratory failure in Guillain-Barré syndrome: a prospective study. Lancet Neurol. 2006 Dec;5(12):1021-8.[Abstract]

    • 34. Duan D, Goemans N, Takeda S, et al. Duchenne muscular dystrophy. Nat Rev Dis Primers. 2021 Feb 18;7(1):13.[Abstract][Full Text]

    • 35. Dalakas MC, Hohlfeld R. Polymyositis and dermatomyositis. Lancet. 2003 Sep 20;362(9388):971-82.[Abstract]

    • 36. Olson SA, Glasgow RR. Acute compartment syndrome in lower extremity musculoskeletal trauma. J Am Acad Orthop Surg. 2005 Nov;13(7):436-44.[Abstract]

    • 37. Greenberg SM, Ziai WC, Cordonnier C, et al. 2022 Guideline for the management of patients with spontaneous intracerebral hemorrhage: a guideline from the American Heart Association/American Stroke Association. Stroke. 2022 Jul;53(7):e282-361.[Abstract][Full Text]

    • 38. Lavi R, Yarnitsky D, Rowe JM, et al. Standard vs atraumatic Whitacre needle for diagnostic lumbar puncture: a randomized trial. Neurology. 2006 Oct 24;67(8):1492-4.[Abstract]

    • 39. Arendt K, Demaerschalk BM, Wingerchuk DM, et al. Atraumatic lumbar puncture needles: after all these years, are we still missing the point? Neurologist. 2009 Jan;15(1):17-20.[Abstract]

    • 40. Nath S, Koziarz A, Badhiwala JH, et al. Atraumatic versus conventional lumbar puncture needles: a systematic review and meta-analysis. Lancet. 2018 Mar 24;391(10126):1197-204.[Abstract]

    • 41. Rochwerg B, Almenawer SA, Siemieniuk RAC, et al. Atraumatic (pencil-point) versus conventional needles for lumbar puncture: a clinical practice guideline. BMJ. 2018 May 22;361:k1920.[Abstract][Full Text]

    • 42. Ahmed SV, Jayawarna C, Jude E. Post lumbar puncture headache: diagnosis and management. Postgrad Med J. 2006 Nov;82(973):713-6.[Abstract][Full Text]

    • 43. Arevalo-Rodriguez I, Ciapponi A, Roqué i Figuls M, et al. Posture and fluids for preventing post-dural puncture headache. Cochrane Database Syst Rev. 2016 Mar 7;(3):CD009199.[Abstract][Full Text]

    • 44. Venkatesan A, Geocadin RG. Diagnosis and management of acute encephalitis: a practical approach. Neurol Clin Pract. 2014 Jun;4(3):206-15.[Abstract][Full Text]

    • 45. Gutierrez J, Issacson RS, Koppel BS. Subacute sclerosing panencephalitis: an update. Dev Med Child Neurol. 2010 Oct;52(10):901-7.[Abstract][Full Text]

    • 46. National Institutes of Health. NIH stroke scale. Nov 2011 [internet publication].[Full Text]

    • 47. Feldmann E, Broderick JP, Kernan WN, et al. Major risk factors for intracerebral hemorrhage in the young are modifiable. Stroke. 2009 Sep 9;302(10):1115-6.[Abstract][Full Text]

    • 48. Brott T, Thalinger K, Hertzberg V. Hypertension as a risk factor for spontaneous intracerebral hemorrhage. Stroke. 1986 Nov-Dec;17(6):1078-83.[Abstract][Full Text]

    • 49. Fazekas F, Niederkorn K, Ebner F, et al. Relevance of neuroimaging in the evaluation of cerebral ischemia. Cerebrovasc Dis. 2009 Apr;27(suppl 1):S1-8.[Abstract]

    • 50. Marks MP. CT in ischemic stroke. Neuroimaging Clin N Am. 1998 Aug;8(3):515-23.[Abstract]

    • 51. Schramm P, Schellinger PD, Klotz E, et al. Comparison of perfusion computed tomography and computed tomography angiography source images with perfusion-weighted imaging and diffusion-weighted imaging in patients with acute stroke of less than 6 hours' duration. Stroke. 2004 Jul;35(7):1652-8.[Abstract][Full Text]

    • 52. Gallego J, Munoz R, Martinez-Vila E. Emergent cerebrovascular disease risk factor weighting: is transient ischemic attack an imminent threat? Cerebrovasc Dis. 2009 Apr;27(suppl 1):S88-S96.[Abstract]

    • 53. Schaefer PW, Romero JM, Grant PE, et al. Diffusion magnetic resonance imaging of acute ischemic stroke. Semin Roentgenol. 2002 Jul;37(3):219-29.[Abstract]

    • 54. Hylek EM, Singer DE. Risk factors for intracranial hemorrhage in outpatients taking warfarin. Ann Intern Med. 1994 Jun 1;120(11):897-902.[Abstract]

    • 55. Catanzaro JN, Meraj PM, Zheng S, et al. Electrocardiographic T-wave changes underlying acute cardiac and cerebral events. Am J Emerg Med. 2008 Jul;26(6):716-20.[Abstract]

    • 56. McCarron MO, Alberts MJ, McCarron P. A systematic review of Terson's syndrome: frequency and prognosis after subarachnoid haemorrhage. J Neurol Neurosurg Psychiatry. 2004 Mar;75(3):491-3.[Abstract][Full Text]

    • 57. Clayman GL, Adams GL, Paugh DR, et al. Intracranial complications of paranasal sinusitis: a combined institutional review. Laryngoscope. 1991 Mar;101(3):234-9.[Abstract]

    • 58. Gallagher RM, Gross CW, Phillips CD. Suppurative intracranial complications of sinusitis. Laryngoscope. 1998 Nov;108(11 Pt 1):1635-42.[Abstract]

    • 59. Rosenfeld EA, Rowley AH. Infectious intracranial complications of sinusitis, other than meningitis, in children: 12-year review. Clin Infect Dis. 1994 May;18(5):750-4.[Abstract]

    • 60. Younis RT, Anand VK, Davidson B. The role of computed tomography and magnetic resonance imaging in patients with sinusitis with complications. Laryngoscope. 2002 Feb;112(2):224-9.[Abstract]

    • 61. Solomon AJ, Arrambide G, Brownlee WJ, et al. Differential diagnosis of suspected multiple sclerosis: an updated consensus approach. Lancet Neurol. 2023 Aug;22(8):750-68.[Abstract]

    • 62. Freedman MS, Thompson EJ, Deisenhammer F, et al. Recommended standard of cerebrospinal fluid analysis in the diagnosis of multiple sclerosis: a consensus statement. Arch Neurol. 2005 Jun;62(6):865-70.[Abstract][Full Text]

    • 63. Winer JB. Treatment of Guillain-Barre syndrome. QJM. 2002 Nov;95(11):717-21.[Abstract][Full Text]

    • 64. Seneviratne U. Guillain-Barre syndrome. Postgrad Med J. 2000 Dec;76(902):774-82.[Abstract][Full Text]

    • 65. Winer JB. Guillain Barre syndrome. Mol Pathol. 2001 Dec;54(6):381-5.[Abstract][Full Text]

    • 66. Duna G, Calabrese LH. Primary angiitis of the central nervous system. In: Kalimo H, ed. Pathology and genetics, cerebrovascular diseases. Basel, Switzerland: ISN Neuropath Press; 2005:147-51.

    • 67. Calabrese LH. Primary angiitis of the central nervous system. In: Rheumatology. 4th ed. Hochberg M, Silman A, Smolen J, et al, eds. St. Louis, MO: Mosby; 2005.

    • 68. Aviv RI, Benseler SM, Silverman ED, et al. MR imaging and angiography of primary CNS vasculitis of childhood. AJNR Am J Neuroradiol. 2006 Jan;27(1):192-9.[Abstract][Full Text]

    • 69. Berman M, Feldman S, Alter M, et al. Acute transverse myelitis: incidence and etiologic considerations. Neurology. 1981 Aug;31(8):966-71.[Abstract]

    • 70. Murthy JM, Reddy JJ, Meena AK, et al. Acute transverse myelitis: MR characteristics. Neurol India. 1999 Dec;47(4):290-3.[Abstract][Full Text]

    • 71. Bayas A, Gold R. Diagnostic principles in myopathies. Fortschr Neurol Psychiatr. 2003 Feb;71(2):61-6.[Abstract]

    • 72. Amato AA, Barohn RJ. Idiopathic inflammatory myopathies. Neurol Clin. 1997 Aug;15(3):615-48.[Abstract]

    • 73. Bohan A, Peter JB. Polymyositis and dermatomyositis (first of two parts). N Engl J Med. 1975 Feb 13;292(7):344-7.[Abstract]

    • 74. Lehmann-Horn F, Jurkat-Rott K, Rudel R, et al. Diagnostics and therapy of muscle channelopathies: guidelines of the Ulm Muscle Center. Acta Myol. 2008 Dec;27(3):98-113.[Abstract]

    • 75. Cherian A, Baheti NN, Kuruvilla A. Muscle channelopathies and electrophysiological approach. Ann Indian Acad Neurol. 2008 Jan;11(1):20-7.[Full Text]

    • 76. Khan NA, Khan AU, Hasan MI, et al. Clinical profile of periodic paralysis. Mymensingh Med J. 2012 Jan;21(1):28-33.[Abstract]

    • 77. Dachowski LJ, DeLaney TF. Photodynamic therapy: the NCI experience and its nursing implications. Oncol Nurs Forum. 1992 Jan-Feb;19(1):63-7.[Abstract]

    • 78. National Institute of Neurological Disorders and Stroke, NIH. Amyotrophic lateral sclerosis fact sheet. Jun 2013 [internet publication].[Full Text]

    • 79. Brooks BR. El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. J Neurol Sci. 1994 Jul;124(suppl):96-107.[Abstract]

    • 80. Mitsumoto H, Chad DA, Pioro EP. Amyotrophic lateral sclerosis. In: Contemporary neurology series, 49. Philadelphia, PA: F.A. Davis Company; 1998.

    • 81. Roggenbuck J, Eubank BHF, Wright J, et al. Evidence-based consensus guidelines for ALS genetic testing and counseling. Ann Clin Transl Neurol. 2023 Nov;10(11):2074-91.[Abstract][Full Text]

    • 82. Harrington TM, Cohen MD, Bartleson JD, et al. Elevation of creatine kinase in amyotrophic lateral sclerosis: potential confusion with polymyositis. Arthritis Rheum. 1983 Feb;26(2):201-5.[Abstract]

    • 83. Dziewas R, Warnecke T, Schnabel M, et al. Neuroleptic-induced dysphagia: case report and literature review. Dysphagia. 2007 Jan;22(1):63-7.[Abstract]

    • 84. Goldfrank LR, Flomenbaum NE, Lewin NA, et al, eds. Goldfrank's toxicologic emergencies 7th ed. New York, NY: McGraw-Hill Professional; 2002.

    • 85. Potteiger JA, Carper MJ, Randall JC, et al. Changes in lower leg anterior compartment pressure before, during, and after creatine supplementation. J Athl Train. 2002 Jun;37(2):157-63.[Abstract][Full Text]

    • 86. Owen CA, Mubarak SJ, Hargens AR, et al. Intramuscular pressures with limb compression clarification of the pathogenesis of the drug-induced muscle-compartment syndrome. N Engl J Med. 1979 May 24;300(21):1169-72.[Abstract]

    • 87. Howe FA, Opstad KS. 1H MR spectroscopy of brain tumours and masses. NMR Biomed. 2003 May;16(3):123-31.[Abstract]

    • 88. Usenius JP, Kauppinen RA, Vainio PA, et al. Quantitative metabolite patterns of human brain tumors: detection by 1H NMR spectroscopy in vivo and in vitro. J Comput Assist Tomogr. 1994 Sep;18(5):705-13.[Abstract]

    • 89. Hallmayer J, Faraco J, Lin L, et al. Narcolepsy is strongly associated with the T-cell receptor alpha locus. Nat Genet. 2009 Jun;41(6):708-11.[Abstract]

    • 90. Hersen M, Turner SM, Beidel DC, eds. Adult psychopathology and diagnosis. 5th ed. Wiley; 2007;380.

Have feedback?
Tell us about your experience
epocrates logo

Sign in to access our clinical decision support tools

Sign inCreate Account
Download Epocrates from the App StoreDownload Epocrates from the Play Store
About UsFeaturesBusiness SolutionsHelp & FeedbackCookie Preferences
© 2026 epocrates, Inc.   Terms of UsePrivacy PolicyEditorial PolicyDo Not Sell or Share My Information